Teva Pharmaceutical Industries Ltd has agreed to pay $420 million to settle shareholder litigation alleging the company hid an anti-competitive scheme to fix the price of generic drugs.

As the Trump administration begins to make its mark on the Medicare drug price negotiation program, litigation over the ...

A New York jury ruled Thursday in a landmark trial that Teva Pharmaceuticals contributed to decades of opioid addiction and deaths in New York state. CNN values your feedback 1.

Teva Pharmaceutical Industries Ltd. said it reached a national settlement agreement worth up to $4.25 billion to resolve thousands of lawsuits over its alleged role in the opioid crisis.

JERUSALEM, Feb 9 (Reuters) - Teva Pharmaceutical Industries , opens new tab said on Wednesday it was bracing to pay as much as $3.6 billion in cash and medicine to settle thousands of lawsuits ...

The decision caps an embarrassing episode for Teva, ... Teva loses ‘buyer’s remorse’ lawsuit over a deal to buy a Mexican drug maker. By Ed Silverman Aug. 2, 2017. Reprints. Alex Hogan/STAT.

Teva Pharmaceuticals and two specialty pharmacies filed separate motions to dismiss a lawsuit in which Humana accuses the drugmakers of partaking in a copay scheme for Copaxone, a multiple ...

The lawsuit claims that Teva “preyed upon the fundamental disconnect between the entities that pay for prescription medications (employers and insurers who pay claims incurred by health plan ...

Teva argues that Eli Lilly induced infringement of two of Teva's patents—11,028,160 and 11,028,161, titled "Treating Refractory Migraines"—which protect the methods for administering the drug ...

Teva Pharmaceuticals said Monday it agreed to pay $512 million to settle a class-action lawsuit alleging that Cephalon, which was later bought by Teva, delayed the availability of the generic ...